Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Supplemental data Table 1. Clinical and immunological patients’ characteristics, described by mean ± standard deviation, frequency, median and interquartile range (IQR) when appropriate. Patients were separated into two groups, according to the development or not of sepsis. Immunological data did not verify normality (using the Kolmogorov-Smirnov test). Groups were compared using the independent paired t test for continuous parametric variables (*), the Mann-Whitney U test for continuous non parametric variables (‡), or the chi-square test for categorical data (▪). A p-value < 0.05 was considered significant. Statistical analyses were performed with R version 3.0.2 software (R foundation for Statistical Computing, Vienna, Austria). Overall population Septic patients Non-Septic patients n=80 n=23 n=57 39 ± 17 32 ± 13 42 ± 18 .02 * 83% (n=60) 83% (n=19) 72% (n=41) .48 ▪ 37 ± 16 42 ± 12 35 ± 8 .002 * Severe brain injury 41% (n=33) 56% (n=13) 35% (n=20) .13 ▪ Severe thoracic injury 81% (n=65) 83% (n=19) 81% (n=46) 1▪ 42 ± 16 48 ± 14 40 ± 16 .03 * Need for vasoactive support in emergency room 41% (n=33) 61% (n=14) 33% (n=19) .04 ▪ Prophylactic antibiotics in emergency room 50% (n=40) 57% (n=13) 47% (n=27) .62 ▪ Mechanical ventilation (MV) 80% (n=64) 96% (n=22) 74% (n=42) .06 ▪ Length of stay in ICU, days 13 ± 14 25 ± 20 8±6 <.0001 * Non-survivors at day 28 0% (n=0) 0% (n=0) 0% (n=0) .06 ▪ D1 7 176 [5 726; 10 460] 7 270 [5 536; 11 470] 7 162 [5 766; 10 410] .6 ‡ D2 5 758 [4 105; 7 620] 5 491 [4 066; 6 654] 5 857 [4 167; 6 692] .5 ‡ Parameters Age (years) Male ISS SAPS II p value mHLA-DR levels , antibodies per cell D3 6 230 [4 352; 10 340] 4 808 [3 247; 8 088] 7 012 [4 580; 10 940] .06 ‡ D4 7 294 [4 584; 9 800] 5 050 [3 509; 9 467] 8 270 [5 094; 10 910] .1 ‡ D2 / D1 .7 [.5 ; 1] .7 [.5 ; .9] .7 [.5 ; 1] .7 ‡ D3 / D2 1.1 [.9 ; 1.3] 1 [.6 ; 1.1] 1.2 [1 ; 1.5] .004 ‡ D4 / D3 1.1 [1 ; 1.3] 1 [.9 ; 1.1] 1.2 [1 ; 1.3] .1 ‡ Variations in mHLA-DR Abbreviations: D: Day; HLA: Human Leucocyte Antigen; ISS: Injury Severity Score; SAPS: Simple Acute Physiology Score; ICU: Intensive Care Unit. Table 2. Sepsis characteristics Type of infection Pulmonary infection Urinary track infection Peritonitis Bacteria involved Mean delay of Incidence occurrence (days) Mechanical Gram- Gram- Mixed positive negative infection ventilation 83% (n=19) 4 53% (n=10) 21% (n=4) 26% (n=5) 95% (n=18) 13% (n=3) 9 67% (n=2) 33% (n=1) 0 NA 4% (n=1) 4 0 0 100% (n=1) NA Regarding pneumonia, when a gram-positive bacteria was involved (i.e. pure or mixed infection), the bacteria responsible was either a Methicillin-sensitive Staphylococcus aureus (80%) or a Streptococcus pneumoniae (20%). The varieties of gram-negative bacteria involved were larger: Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae or oxytoca.